Omnicell Price to Sales Ratio 2010-2025 | OMCL

Historical PS ratio values for Omnicell (OMCL) over the last 10 years. The current P/S ratio for Omnicell as of July 30, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Omnicell P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-07-30 29.70 1.21
2025-03-31 34.96 $24.52 1.43
2024-12-31 44.52 $24.11 1.85
2024-09-30 43.60 $23.20 1.88
2024-06-30 27.07 $23.67 1.14
2024-03-31 29.23 $24.23 1.21
2023-12-31 37.63 $25.33 1.49
2023-09-30 45.04 $26.09 1.73
2023-06-30 73.67 $27.13 2.72
2023-03-31 58.67 $27.72 2.12
2022-12-31 50.42 $27.90 1.81
2022-09-30 87.03 $27.90 3.12
2022-06-30 113.75 $26.44 4.30
2022-03-31 129.49 $25.06 5.17
2021-12-31 180.44 $23.84 7.57
2021-09-30 148.43 $23.05 6.44
2021-06-30 151.45 $21.81 6.94
2021-03-31 129.87 $20.70 6.27
2020-12-31 120.02 $20.53 5.85
2020-09-30 74.66 $20.62 3.62
2020-06-30 70.62 $21.04 3.36
2020-03-31 65.58 $21.42 3.06
2019-12-31 81.72 $20.95 3.90
2019-09-30 72.27 $20.39 3.54
2019-06-30 86.03 $20.07 4.29
2019-03-31 80.84 $19.73 4.10
2018-12-31 61.24 $19.54 3.13
2018-09-30 71.90 $19.39 3.71
2018-06-30 52.45 $19.18 2.73
2018-03-31 43.40 $19.18 2.26
2017-12-31 48.50 $18.62 2.61
2017-09-30 51.05 $18.30 2.79
2017-06-30 43.10 $18.27 2.36
2017-03-31 40.65 $18.36 2.21
2016-12-31 33.90 $19.11 1.77
2016-09-30 38.30 $17.90 2.14
2016-06-30 34.23 $16.56 2.07
2016-03-31 27.87 $14.80 1.88
2015-12-31 31.08 $13.16 2.36
2015-09-30 31.10 $12.93 2.40
2015-06-30 37.71 $12.57 3.00
2015-03-31 35.10 $12.39 2.83
2014-12-31 33.12 $12.05 2.75
2014-09-30 27.33 $11.68 2.34
2014-06-30 28.71 $11.23 2.56
2014-03-31 28.62 $11.01 2.60
2013-12-31 25.53 $10.70 2.38
2013-09-30 23.68 $10.38 2.28
2013-06-30 20.55 $10.26 2.00
2013-03-31 18.88 $9.81 1.92
2012-12-31 14.87 $9.18 1.62
2012-09-30 13.90 $8.39 1.66
2012-06-30 14.64 $7.79 1.88
2012-03-31 15.21 $7.39 2.06
2011-12-31 16.52 $7.20 2.29
2011-09-30 13.78 $7.06 1.95
2011-06-30 15.59 $6.86 2.27
2011-03-31 15.24 $6.70 2.28
2010-12-31 14.45 $6.66 2.17
2010-09-30 13.08 $6.65 1.97
2010-06-30 11.69 $6.64 1.76
2010-03-31 14.03 $6.65 2.11
2009-12-31 11.69 $6.68 1.75
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.387B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.937B 59.72
Hims & Hers Health (HIMS) United States $13.490B 140.16
Doximity (DOCS) United States $11.213B 51.91
Tempus AI (TEM) United States $10.091B 0.00
IRhythm Technologies (IRTC) United States $4.366B 0.00
Inspire Medical Systems (INSP) United States $3.822B 59.72
Hinge Health (HNGE) United States $3.402B 0.00
Privia Health (PRVA) United States $2.375B 162.33
10x Genomics (TXG) United States $1.724B 0.00
Phreesia (PHR) United States $1.614B 0.00
Enovis (ENOV) United States $1.561B 8.70
Schrodinger (SDGR) United States $1.553B 0.00
Azenta (AZTA) United States $1.553B 72.17
Clover Health Investments (CLOV) United States $1.471B 0.00
Evolent Health (EVH) United States $1.105B 94.10
Claritev (CTEV) United States $0.635B 0.00
Fulgent Genetics (FLGT) United States $0.535B 0.00
Standard BioTools (LAB) United States $0.528B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Butterfly Network (BFLY) United States $0.453B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.328B 728.00
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.273B 0.00
Nyxoah SA (NYXH) Belgium $0.255B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.218B 0.00
CapsoVision (CV) United States $0.210B 0.00
Zepp Health (ZEPP) Netherlands $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
American Well (AMWL) United States $0.129B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
MDxHealth SA (MDXH) Belgium $0.117B 0.00
CareCloud (CCLD) United States $0.100B 3.82
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.078B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.042B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
PROFUSA (PFSA) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00